The Centre for Drug Research and Development (CDRD) has launched Sitka Biopharma, a spin-out which looks to commercialise bladder cancer treatment. The new company was launched through the CDRD’s tech transfer unit CDRD Ventures, and utilises research which emerged through a collaboration between the organisation and the University of British Columbia. Sitka’s technology offers a…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.